Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALTSCHULE M. D. Use of chlorpromazine and reserpine in mental disorders. N Engl J Med. 1956 Mar 15;254(11):515–519. doi: 10.1056/NEJM195603152541105. [DOI] [PubMed] [Google Scholar]
- BARSA J. A., KLINE N. S. Combined reserpine-chlorpromazine in treatment of disturbed psychotics. AMA Arch Neurol Psychiatry. 1955 Sep;74(3):280–286. doi: 10.1001/archneurpsyc.1955.02330150046006. [DOI] [PubMed] [Google Scholar]
- BRACHA S., HES J. P. The influence of reserpine on a disturbed male ward and a method for assessing this. J Ment Sci. 1956 Jul;102(428):546–549. doi: 10.1192/bjp.102.428.546. [DOI] [PubMed] [Google Scholar]
- BROOKS G. W. Experience with the use of chlorpromazine and reserpine in psychiatry, with special reference to the significance and management of extrapyramidal dysfunction. N Engl J Med. 1956 Jun 14;254(24):1119–1123. doi: 10.1056/NEJM195606142542403. [DOI] [PubMed] [Google Scholar]
- COLOMBATI S., BENASSI P. Impiego di un alcaloide della Rauwolfia in neuropsichiatria. Gazz Med Ital. 1954 Oct;113(10):301–303. [PubMed] [Google Scholar]
- FLACH F. F. Clinical effectiveness of reserpine. Ann N Y Acad Sci. 1955 Apr 15;61(1):161–166. doi: 10.1111/j.1749-6632.1955.tb42462.x. [DOI] [PubMed] [Google Scholar]
- GLESINGER B. Evaluation of lithium in treatment of psychotic excitement. Med J Aust. 1954 Feb 20;41(1 8):277–283. doi: 10.5694/j.1326-5377.1954.tb85334.x. [DOI] [PubMed] [Google Scholar]
- GLYNN J. D. Rauwolfia serpentina (serpasil) in psychiatry. J Neurol Neurosurg Psychiatry. 1955 Aug;18(3):225–227. doi: 10.1136/jnnp.18.3.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KINROSS-WRIGHT V. Chlorpromazine and reserpine in the treatment of psychoses. Ann N Y Acad Sci. 1955 Apr 15;61(1):174–182. doi: 10.1111/j.1749-6632.1955.tb42464.x. [DOI] [PubMed] [Google Scholar]
- KIRKPATRICK W. L., SANDERS F. Clinical evaluation of reserpine in a state hospital. Ann N Y Acad Sci. 1955 Apr 15;61(1):123–143. doi: 10.1111/j.1749-6632.1955.tb42459.x. [DOI] [PubMed] [Google Scholar]
- LUTTRELL R. R., MORRISON A. V. A preliminary report on the tranquilizing effect of reserpine. Ann N Y Acad Sci. 1955 Apr 15;61(1):183–187. doi: 10.1111/j.1749-6632.1955.tb42465.x. [DOI] [PubMed] [Google Scholar]
- OLTMAN J. E., FRIEDMAN S. Analysis of temporal factors in manic-depressive psychosis, with particular reverence to the effect of shock therapy. Am J Psychiatry. 1950 Jul;107(1):57–68. doi: 10.1176/ajp.107.1.57. [DOI] [PubMed] [Google Scholar]
- RICE D. The use of lithium salts in the treatment of manic states. J Ment Sci. 1956 Jul;102(428):604–611. doi: 10.1192/bjp.102.428.604. [DOI] [PubMed] [Google Scholar]
- SARWER-FONER G. J., OGLE W. Psychodynamic aspects of reserpine: its uses and effects in open psychiatric settings. Can Psychiatr Assoc J. 1956 Jan;1(1):11–17. doi: 10.1177/070674375600100103. [DOI] [PubMed] [Google Scholar]
- SCHOU M., JUEL-NIELSEN N., STROMGREN E., VOLDBY H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954 Nov;17(4):250–260. doi: 10.1136/jnnp.17.4.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SOMMERNESS M. D., LUCERO R. J., HAMLON J. S., ERICKSON J. L., MATTHEWS R. A controlled study of reserpine on chronically disturbed patients. AMA Arch Neurol Psychiatry. 1955 Sep;74(3):316–319. doi: 10.1001/archneurpsyc.1955.02330150082012. [DOI] [PubMed] [Google Scholar]
- VAUGHAN G. F., LEIBERMAN D. M., COOK L. C. Chlorpromazine in psychiatry. Lancet. 1955 May 28;268(6874):1083–1087. doi: 10.1016/s0140-6736(55)90587-0. [DOI] [PubMed] [Google Scholar]
- ZELLER W. W., GRAFFAGNINO P. N., CULLEN C. F., RIETMAN H. J. Use of chlorpromazine and reserpine in the treatment of emotional disorders. J Am Med Assoc. 1956 Jan 21;160(3):179–184. doi: 10.1001/jama.1956.02960380027008. [DOI] [PubMed] [Google Scholar]